clinical trials

GSK hits go on pivotal TIM-3 lung cancer trial after phase 2 clears bar for advancement
Fierce Biotech
Wed, 10/5/22 - 10:49 am
GSK
lung cancer
clinical trials
cobolimab
non-small cell lung cancer
OncoSec sheds 45% of staff to fund IL-12 drug through Keytruda combo trial
Fierce Biotech
Wed, 10/5/22 - 10:31 am
OncoSec Medical
melanoma
clinical trials
Keytruda
layoffs
Tavo
After Adamis' COVID-19 flop, company weighs future and warns layoffs could be in the cards
Fierce Pharma
Tue, 10/4/22 - 11:39 pm
Adamis
clinical trials
Tempol
layoffs
KalVista ends a PhII study early after patients suffer severe and life-threatening side effects
Endpoints
Tue, 10/4/22 - 11:37 pm
KalVista
KVD824
clinical trials
hereditary angiodema
Pfizer’s PARP inhibitor combo treatment passes primary endpoint — but details are slim
Endpoints
Tue, 10/4/22 - 11:06 am
Pfizer
Xtandi
Talzenna
PARP inhibitors
Medivation
clinical trials
prostate cancer
Sites on wheels: bringing the clinical trial to the patient’s doorstep
Clinical Trials Arena
Tue, 10/4/22 - 10:38 am
clinical trials
decentralized clinical trials
remote clinical trials
Kezar to commence Phase IIa autoimmune hepatitis therapy trial
Clinical Trials Arena
Tue, 10/4/22 - 10:36 am
Kezar Life Sciences
clinical trials
zetomipzomib
autoimmune hepatitis
Biogen, Denali begin late-stage testing of Parkinson’s drug
BioPharma Dive
Mon, 10/3/22 - 11:28 pm
Biogen
Denali Therapeutics
Parkinson's Disease
clinical trials
BIIB122
Scandion's shares fall after oncology biotech reports PhII fail
Endpoints
Mon, 10/3/22 - 10:15 am
Scandion Oncology
clinical trials
colorectal cancer
SCO-101
After $100M deal, J&J links gene therapy to improved vision in early-phase trial
Fierce Biotech
Mon, 10/3/22 - 10:11 am
JNJ
gene therapy
clinical trials
retinal disease
MeiraGTx
X-linked retinitis pigmentosa
Zealand Pharma reports data from Phase III short bowel syndrome trial
Clinical Trials Arena
Mon, 10/3/22 - 10:03 am
Zealand Pharma
clinical trials
glepaglutide
short bowel syndrome
New pediatric data shoot Rocket's gene therapy toward phase 2, leaving behind FDA concerns
Fierce Biotech
Sun, 10/2/22 - 08:04 pm
Rocket Pharmaceuticals
gene therapy
clinical trials
RP-A501
Ocaliva fails NASH trial just as Intercept charts path toward FDA application
Fierce Pharma
Fri, 09/30/22 - 12:31 pm
Intercept Pharma
NASH
obeticholic acid
Ocaliva
clinical trials
FDA
Kling doses first subject in Phase Ib solid tumour antibody trial
Clinical Trials Arena
Fri, 09/30/22 - 11:02 am
Kling Biotherapeutics
KBA1412-101
solid tumors
clinical trials
Kinarus stops midphase study in hospitalized COVID-19 patients early, adding to long list of failed trials
Fierce Biotech
Fri, 09/30/22 - 10:55 am
Kinarus Therapeutics
COVID-19
clinical trials
KIN001
BMS and ConcertAI launch digital trial solution for oncology
Clinical Trials Arena
Fri, 09/30/22 - 10:54 am
Bristol Myers Squibb
ConcertAI
clinical trials
oncology
hematology
urology
With cash dwindling, Axcella shares look at blinded NASH data
Fierce Biotech
Thu, 09/29/22 - 10:11 am
Axcella
NASH
clinical trials
AXA1125
Biohaven's ALS drug fails to meet study goals
Yahoo/Reuters
Thu, 09/29/22 - 10:07 am
Biohaven
ALS
clinical trials
troriluzole
Galecto links blood cancer prospect to reduced fibrosis in early data drop
Fierce Biotech
Thu, 09/29/22 - 09:51 am
Galecto
clinical trials
myelofibrosis
GB2064
Lecanemab can; now the wait for details begins
EP Vantage
Wed, 09/28/22 - 11:45 am
Biogen
Eisai
lecanemab
clinical trials
Alzheimer's disease

Pages